AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas

Caitlin D. May(The University of Texas MD Anderson Cancer Center), Keila E. Torres(The University of Texas MD Anderson Cancer Center)
BMC Cancer
November 14, 2015
Cited by 32


Related Papers